NO155885C - Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper. - Google Patents

Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.

Info

Publication number
NO155885C
NO155885C NO813334A NO813334A NO155885C NO 155885 C NO155885 C NO 155885C NO 813334 A NO813334 A NO 813334A NO 813334 A NO813334 A NO 813334A NO 155885 C NO155885 C NO 155885C
Authority
NO
Norway
Prior art keywords
tiazold
ulcus
derivatives
properties
preparation
Prior art date
Application number
NO813334A
Other languages
English (en)
Other versions
NO155885B (no
NO813334L (no
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO155885(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO813334L publication Critical patent/NO813334L/no
Publication of NO155885B publication Critical patent/NO155885B/no
Publication of NO155885C publication Critical patent/NO155885C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
NO813334A 1980-10-02 1981-10-01 Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper. NO155885C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (3)

Publication Number Publication Date
NO813334L NO813334L (no) 1982-04-05
NO155885B NO155885B (no) 1987-03-09
NO155885C true NO155885C (no) 1987-06-17

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813334A NO155885C (no) 1980-10-02 1981-10-01 Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.

Country Status (36)

Country Link
US (1) US4375547A (no)
EP (1) EP0049618B1 (no)
JP (1) JPS5791980A (no)
KR (1) KR850001795B1 (no)
AR (1) AR241439A1 (no)
AU (1) AU542553B2 (no)
BG (1) BG60249B2 (no)
CA (1) CA1166248A (no)
CS (1) CS227015B2 (no)
CY (1) CY1351A (no)
DD (1) DD200371A5 (no)
DE (1) DE3171819D1 (no)
DK (2) DK164056C (no)
EG (1) EG15678A (no)
ES (2) ES8301950A1 (no)
FI (2) FI813058L (no)
GB (1) GB2084581B (no)
GR (1) GR75023B (no)
HK (1) HK15987A (no)
HU (1) HU188697B (no)
IE (1) IE51603B1 (no)
IL (1) IL63980A (no)
LU (1) LU88293I2 (no)
MX (1) MX5723A (no)
MY (1) MY8700247A (no)
NL (1) NL930107I2 (no)
NO (1) NO155885C (no)
NZ (1) NZ198523A (no)
PH (1) PH18135A (no)
PL (2) PL130526B1 (no)
PT (1) PT73757B (no)
RO (2) RO85815B (no)
SU (1) SU1184443A3 (no)
UA (1) UA6081A1 (no)
YU (1) YU42728B (no)
ZA (1) ZA816817B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
FI840474A (fi) * 1983-02-07 1984-08-08 Lilly Co Eli Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
DE3784698D1 (de) * 1987-04-06 1993-04-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
EP0515121B1 (en) * 1991-05-21 2000-11-02 Eli Lilly And Company Process for preparing intermediates to nizatidine and related compounds
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
EP0641763B1 (en) * 1992-05-12 1997-01-08 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
KR20000036016A (ko) * 1996-09-11 2000-06-26 독터. 호르스트 하스칼, 잉에 린스 니자티딘의 제조 방법
IT1299198B1 (it) * 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
WO2000028988A1 (en) 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EA034430B1 (ru) 2013-07-19 2020-02-06 Бёрингер Ингельхайм Ветмедика Гмбх Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина
ES2883448T3 (es) 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
NO155885B (no) 1987-03-09
ES514868A0 (es) 1983-05-01
AU7594581A (en) 1982-04-08
FI813058L (fi) 1982-04-03
NZ198523A (en) 1985-12-13
PT73757B (en) 1983-01-13
PL233295A1 (no) 1982-12-20
SU1184443A3 (ru) 1985-10-07
KR830007602A (ko) 1983-11-04
PH18135A (en) 1985-04-03
JPH021141B2 (no) 1990-01-10
DK164056B (da) 1992-05-04
DD200371A5 (de) 1983-04-20
YU236481A (en) 1983-10-31
RO85815B (ro) 1984-11-30
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
MY8700247A (en) 1987-12-31
AR241439A1 (es) 1992-07-31
KR850001795B1 (ko) 1985-12-21
PL130626B1 (en) 1984-08-31
DK435181A (da) 1982-05-12
PL130526B1 (en) 1984-08-31
GB2084581A (en) 1982-04-15
ZA816817B (en) 1983-05-25
CA1166248A (en) 1984-04-24
GB2084581B (en) 1985-02-27
GR75023B (no) 1984-07-12
EP0049618B1 (en) 1985-08-14
MX5723A (es) 1993-12-01
PL238035A1 (en) 1983-02-28
RO82215A (ro) 1983-07-07
EG15678A (en) 1986-12-30
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
HK15987A (en) 1987-02-27
AU542553B2 (en) 1985-02-28
RO82215B (ro) 1983-06-30
PT73757A (en) 1981-11-01
BG60249B1 (bg) 1994-03-24
IE51603B1 (en) 1987-01-21
BG60249B2 (en) 1994-03-24
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
IE812285L (en) 1982-04-02
YU42728B (en) 1988-12-31
ES8306135A1 (es) 1983-05-01
IL63980A (en) 1986-04-29
DK12391A (da) 1991-01-24
NL930107I1 (nl) 1993-10-18
NL930107I2 (nl) 1997-02-03
HU188697B (en) 1986-05-28
NO813334L (no) 1982-04-05
JPS5791980A (en) 1982-06-08
RO85815A (ro) 1984-11-25
IL63980A0 (en) 1982-01-31
DK164056C (da) 1992-09-28
DK12391D0 (da) 1991-01-24
DE3171819D1 (en) 1985-09-19
ES505950A0 (es) 1983-01-01
ES8301950A1 (es) 1983-01-01
EP0049618A1 (en) 1982-04-14
DK167759B1 (da) 1993-12-13
US4375547A (en) 1983-03-01

Similar Documents

Publication Publication Date Title
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO162075C (no) Fremgangsmaate for fremstilling av polymerer med hydroksaminfunksjoner.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO822704L (no) Fremgangsmaate for fremstilling av insulinderivater.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO800664L (no) Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
NO167290C (no) Analogifremgangsmaate for fremstilling av rifamycinderivater.
NO157652C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158736C (no) Analogifremgangsmaate for fremstilling av tetrahydropyridinderivater.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN OCTOBER 2001